Connor, Clark & Lunn Investment Management (CC&L)’s Repros Therapeutics Inc. RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-37,500
| Closed | -$45K | – | 1068 |
|
|
2017
Q1 | $45K | Sell |
37,500
-200
| -0.5% | -$240 | ﹤0.01% | 876 |
|
|
2016
Q4 | $50K | Sell |
37,700
-1,000
| -3% | -$1.33K | ﹤0.01% | 858 |
|
|
2016
Q3 | $81K | Hold |
38,700
| – | – | ﹤0.01% | 786 |
|
|
2016
Q2 | $62K | Hold |
38,700
| – | – | ﹤0.01% | 824 |
|
|
2016
Q1 | $38K | Hold |
38,700
| – | – | ﹤0.01% | 809 |
|
|
2015
Q4 | $47K | Buy |
+38,700
| New | +$47K | ﹤0.01% | 790 |
|